New Report Big Pharma Companies Current Agreement and Future Extension

About This Presentation
Title:

New Report Big Pharma Companies Current Agreement and Future Extension

Description:

Browse the Report @ . Partnering Deals and Alliances with Big Pharma report contains over 3,000 links to online copies of actual partnering deals as recorded at Current Agreement, together with contract documents if submitted to the Securities Exchange Commission by bigpharma and their partners. – PowerPoint PPT presentation

Number of Views:70

less

Transcript and Presenter's Notes

Title: New Report Big Pharma Companies Current Agreement and Future Extension


1
Partnering Deals and Alliances with Big Pharma
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
Published March 2014 Single User PDF US
3295 Corporate User PDF US 16495
2
Partnering Deals and Alliances with Big Pharma
  • Delivery of this report will take 1-3 days after
    purchase.
  • The Partnering Deals and Alliances with Big
    Pharma report provides the most comprehensive and
    in-depth insight into the dealmaking interests
    and activity of the worlds leading fifty big
    pharma companies.
  • Delivery of this report will take 1-3 days after
    purchase.
  • View the Complete report of 816 Pages

Reach us at 1 888 391 5441 sales_at_sandlerresear
ch.org
3
Partnering Deals and Alliances with Big Pharma
  • Partnering Deals and Alliances with Big Pharma
    provides the user with the following key
    benefits
  • Detailed partnering activity profiles for each of
    the top 50 big pharma companies
  • Over 300 charts showing a companys dealmaking
    activity since 2007, allowing quick
    identification potential partners
  • Partnering therapy focus revealed
  • Partnering activity since 2009 number of deals
    per year
  • Full listing of partnering deals
  • Activity by deal type
  • Activity by industry sector
  • Activity by phase of development
  • Activity by technology type
  • Activity by therapeutic area

Get Sample of the Report _at_ http//www.reportsnrepo
rts.com/contacts/RequestSample.aspx?name56445 .
4
Partnering Deals and Alliances with Big Pharma
  • Partnering Deals and Alliances with Big Pharma
    provides the user with the following key
    benefits
  • Comprehensive access to over 3,000 partnering
    deals as recorded at Current Agreement, together
    with contract documents if available
  • Insight into the terms included in a partnering
    agreement, together with real world clause
    examples, via contract documents
  • Understand the key deal terms the company has
    agreed in previous deals
  • Undertake due diligence to assess suitability of
    your proposed deal terms for partner companies
  • The Partnering Deals and Alliances with Big
    Pharma report provides the most comprehensive and
    in-depth insight into the dealmaking interests
    and activity of the worlds leading fifty big
    pharma companies.
  • This premier report provides all the information
    you require to better understand big pharma
    partnering.

Inquire for Discount _at_ http//www.reportsnreports.
com/contacts/Discount.aspx?name56445 .
5
Partnering Deals and Alliances with Big Pharma
  • One of the key aspects of partnering is finding
    those companies that are potential candidates for
    the development and commercialization of the next
    generation of therapies. A lot of resources are
    spent on finding partners, identifying their
    interests and making contact to initiate
    discussions.
  • Using this report, dealmakers will effectively
    and efficiently target their partnering
    activities to deliver the companys business
    development objectives. Over 300 charts allow
    quick understanding of each big pharma companies
    dealmaking trends over the last four years.
  • This report contains over 3,000 links to online
    copies of actual partnering deals as recorded at
    Current Agreement, together with contract
    documents if submitted to the Securities Exchange
    Commission by bigpharma and their partners.
  • Contract documents provide the answers to
    numerous questions about a prospective partners
    flexibility on a wide range of important issues,
    many of which will have a significant impact on
    each partys ability to derive value from the
    deal.

Delivery of this report will take 1-3 days after
purchase.
6
Partnering Deals and Alliances with Big Pharma
  • The initial chapters of this report provide an
    orientation of big pharmas dealmaking and
    business activities.
  • Chapter 1 provides an introduction to the report,
    whilst chapter 2 lists the top 50 leading big
    pharma companies based on 2012 pharmaceutical
    revenues and dealmaking activity since 2009.
  • Chapter 3 reviews the top partnering and MA
    deals of 2009-2014 according to reported deal
    size.
  • Chapter 4 provides a summary on best practice on
    how to submit an opportunity to big pharma, to
    ensure building of relationships and to obtain a
    prompt assessment and response from the business
    development function of the prospective partner.
  • Chapter 5 lists forthcoming partnering events
    where valuable face to face meetings with big
    pharma provide a highly effective means of
    obtaining interest in novel opportunities. These
    events are where dealmaking gets initiated
    through numerous back to back meetings.

Reach us at 1 888 391 5441 sales_at_sandlerresear
ch.org
7
Partnering Deals and Alliances with Big Pharma
  • Key benefits
  • Partnering Deals and Alliances with Big Pharma
    provides the user with the following key
    benefits
  • Detailed partnering activity profiles for each of
    the top 50 big pharma companies
  • Over 300 charts showing a companys dealmaking
    activity since 2009, allowing quick
    identification potential partners
  • Partnering therapy focus revealed
  • Partnering activity since 2009 number of deals
    per year
  • Full listing of partnering deals
  • Activity by deal type
  • Activity by industry sector
  • Activity by phase of development
  • Activity by technology type
  • Activity by therapeutic area

Reach us at 1 888 391 5441 sales_at_sandlerresear
ch.org
8
Partnering Deals and Alliances with Big Pharma
  • Report scope
  • Partnering Deals and Alliances with Big Pharma is
    intended to provide the reader with an in-depth
    understanding of the partnering activities of the
    leading fifty big pharma companies worldwide,
    enabling the effective assessment and selection
    of partners of choice, based on the latest
    knowledge of a companys partnering.
  • Report includes
  • Partnering Deals and Alliances with Big Pharma
    included
  • Analyzing actual company agreements allows
    assessment
  • Benefits
  • View the Complete report of 816 Pages

Reach us at 1 888 391 5441 sales_at_sandlerresear
ch.org
Write a Comment
User Comments (0)